Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open:Futures: FTSE +0.13%, DAX +0.10%, CAC40 +0.15%

Aug 19 ,2025

  • Synopsis

    • European equity markets are set to open higher, whilst Asian equities mixed Tuesday. Quiet start to trade with Hong Kong, Japan, Korea and Taiwan benchmarks little changed. Mainland China picking up gains. Australian index weighed down by negative reaction to CSL.AU's earnings. S&P 500 futures flat afterhours.

    • On today's agenda, there's Aqua Nor (through Thur), Norway's minister of fisheries and oceans Næss attends, company exec among the speakers/panellists. Norway's PM Støre participates in Party leader debate on TV 2 at 21:45CET. Wyoming Blockchain Symposium. Fed's Bowman speech at 19:10BST and Waller speech at 16:00BST on Wed.

    • Zelensky and European leaders met Trump at White House on Monday. Talks described as positive with discussions largely on security guarantees and Trump open to some US involvement. Trump later said arrangements underway for meeting between Zelensky and Putin with Trump involved in potential a trilateral summit. While a big press focus, meetings still did not provide much direction for the market given no suggestions about easing of sanctions and Trump seemingly putting additional secondary tariffs on backburner.

    • Quiet macro calendar due today includes with Portugal Jul PPI.

    • On the reporting front, Coloplast (COLO.B.DC) reported Q3 earnings and confirmed its guidance for 2025. Also in Nordics, Ambea AB (AMBEA.SS), Scatec (SCATC.NO), Odfjell Drilling (ODL.NO), Norse Atlantic (NORSE.NO), and Jyske Bank (JYSK.DC) reported Q2 earnings. .In DACHs, HUBER+SUHNER (HUBN.SW), Flughafen Wien (FLU.AV) and DocMorris (DOCM.SW) amongst other to report earnings this morning. In France, Aeroport de Paris (ADP.FP) reported total Paris Aeroport July traffic figures. Also due to report today includes, International Workplace Group (IWG.LN), Odfjell (ODF.NO) and Latour Investment (LATO.B.SS).

  • Politics/Macro/World News

    • Donald Trump says US to 'co-ordinate' Ukraine's security with Europe - FT

    • Germany's Merz says Putin, Zelenskiy to meet within next two weeks - Reuters

    • UK Drops Mandate for Apple 'Backdoor' on Americans, Gabbard Says - Bloomberg

    • Brussels heads for a fall fight over limiting subsidies to big farms - Politico

    • Reeves eyes property tax raid on the wealthy - The Telegraph

  • Top company news

    • Earnings/updates

      • DAHCs

        • PSPN.SW (PSP Swiss Property) -- reports Q2 EPS ex-items CHF1.24 vs year-ago CHF1.24

        • MED.SW (Medartis Holding) -- reports H1 core EBITDA CHF21.7M vs FactSet CHF20.6M [2 est, CHF20-21.1M]

        • HUBN.SW (HUBER+SUHNER) -- reports H1 net income CHF36.6M vs FactSet CHF31M [1 est]

        • SBS.GR (Stratec) -- reports Q2 EPS €0.15 vs year-ago €0.37

        • DOCM.SW (DocMorris) -- reports H1 net income (CHF61.6M) vs FactSet (CHF59.4M) [3 est, (CHF61.1)-(56M)]

        • BCGE.SW (Banque Cantonal de Geneve) -- reports H1 net income CHF94.0M vs FactSet CHF107.9M [1 est]

        • BSLN.SW (Basilea Pharmaceutica) -- reports H1 net income CHF15.8M vs FactSet CHF24.6M [1 est]; updates FY guidance

        • FLU.AV (Flughafen Wien) -- reports H1 net income €115.1M, +6% vs year-ago €108.4M; confirms FY outlook

        • DR0.GR (Deutsche Rohstoff) -- reports H1 net income €15.5M vs year-ago €24.8M

      • Benelux

        • NYXH.BB (Nyxoah) -- reports Q2 EPS (€0.55) vs FactSet (€0.57) [6 est, (€0.65)-(0.51)]

      • France

        • ADP.FP (Aeroport de Paris) -- reports Total Paris Aeroport July traffic 10.2M, +3.5% y/y

      • Nordics

        • TIETO.FH (Tietoevry) -- Oyj announces court ruling on a customer dispute remains valid; contributes to Tietoevry's second-half financial performance

        • SCATC.NO (Scatec) -- reports Q2 EPS NOK1.71 vs year-ago (NOK0.34)

        • AMBEA.SS (Ambea AB) -- reports Q2 EPS SEK1.13 vs FactSet SEK1.50 [2 est, SEK1.18-1.81]

        • BICO.SS (BICO Group) -- reports Q2 EPS (SEK2.55) vs FactSet (SEK1.20) [2 est, (SEK1.60)-(0.80)]

        • ODL.NO (Odfjell Drilling) -- reports Q2 EPS $0.17 vs FactSet $0.11 [5 est, $0.06-0.13], raises dividend +12.5%

        • MULTI.NO (Multiconsult) -- reports Q2 EPS NOK1.45 vs FactSet NOK2.45 [4 est, NOK2.20-2.92]

        • NORSE.NO (Norse Atlantic) -- reports Q2 net income ($5.9M) vs year-ago ($31.9M)

        • SPIR.NO (Spir Group) -- reports Q2 net income NOK9.0M vs year-ago NOK9.4M

        • IDUN.B.SS (Idun Industrier) -- reports Q2 EPS SEK2.00 vs year-ago SEK1.80

        • GIGA.NO (Gigante Salmon) -- reports Q2 net income (NOK3.6M) vs FactSet (NOK0.5M) [2 est, (NOK6)-5M]

        • PION.B.SS (PION Group) -- reports Q2 EPS (SEK0.05) vs year-ago (SEK0.42)

        • TRIFOR.DC (Trifork Holding) -- reports Q2 EBIT €1.1M vs FactSet €2.6M [4 est, €1.8-3M]

        • STAR.B.SS (Starbreeze) -- reports Q2 EPS (SEK0.02) vs year-ago (SEK0.05)

        • SALME.NO (Salmon Evolution) -- reports Q2 EPS (NOK0.16) vs FactSet (NOK0.05) [6 est, (NOK0.13)-0.00]

        • SES.SS (Scandinavian Enviro Systems) -- reports Q2 EPS (SEK0.02) vs year-ago SEK0.04

        • COLO.B.DC (Coloplast) -- reports Q3 net income DKK805M vs consensus DKK968M; FY24/25 guidance is unchanged

        • MAHA.A.SS (Maha Capital) -- reports Q2 net income ($20.2M) vs year-ago ($22.7M)

        • JYSK.DC (Jyske Bank) -- reports Q2 net income DKK1.28B vs FactSet DKK1.04B [6 est, DKK878.7-1.13B]

      • Also due to report today includes

        • Earnings:

          • Benelux: EVS Broadcast Equipment (EVS.BB)

          • Denmark: SP Group (SPG.DC), MT Hojgaard Holding (MTHH.DC)

          • Norway: Odfjell (ODF.NO), Cambi (CAMBI.NO), Måsøval (MAS.NO), Nordhealth (NORDH.NO)

          • Other: Mobile TeleSystems (MTSS.RU)

          • Sweden: Latour Investment (LATO.B.SS), Bahnhof (BAHN.B.SS), FormPipe Software (FPIP.SS)

          • Switzerland: SKAN Group (BVHN.SW)

          • UK: International Workplace Group (IWG.LN), Tribal Group (TRB.LN)

        • Traffic: Flughafen Wien (FLU.AV)

    • M&A

      • PHIL.IM (Philogen) -- announces completion of antitrust clearance and closing of the OncoACP3 licensing agreement with RayzeBio, a Bristol Myers Squibb company, with a potential value of up to $1.35B plus royalties

      • TRIFOR.DC (Trifork Holding) -- agrees to divest 51% of Trifork Security to Quadrum Capital (Wingmen Solutions ApS) for an undisclosed sum

      • ALPHA.GA (Alpha Bank SA) -- UniCredit announces UniCredit Bank Romania merger with Alpha Bank Romania successfully completed

      • PION.B.SS (PION Group) -- sells subsidiary Roi Rekrytering Sverige AB to Optivio AB for SEK 200K

      • 542772.IN (360 One Wam) -- consummates previously announced transaction with UBS including acquisition UBS's onshore wealth management business in India

      • Bank of Montreal holds discussions with Euroz Hartleys - Australian Financial Review

    • Healthcare

      • SAN.FP (Sanofi) -- Singapore approves Beyfortus (nirsevimab) for prevention of RSV in newborns and infants

      • 1K0.GR (IGM Biosciences) -- SEC filing: SCHEDULE 13D/A (Filed by Topsoe Holding A/S)

      • 1K0.GR (IGM Biosciences) -- SEC filing: SCHEDULE 13D/A (Filed by BAKER BROS. ADVISORS LP)

      • BIM.FP (bioMerieux) -- receives U.S. 510(k) clearance and CLIA-waiver for Anterior Nasal Swab specimens

      • IDIA.SW (Idorsia) -- publishes end results of repurchase offer for its 2025 and 2028 convertible bonds

      • SANN.SW (Santhera Pharmaceuticals Holding) -- Santhera signs agreement with Uniphar for distribution of AGAMREE (Vamorolone) in five GCC (Gulf Cooperation Council) countries

      • CANTA.SS (Cantargia) -- appoints Dr Hilde Steineger as CEO, effective 1-Sep

      • BICO.SS (BICO Group) -- repurchased convertible bonds to a total nominal amount of SEK 98M

    • Other

      • NXT.LN (Next) -- PLC announces non-discretionary share repurchase programme 19-Aug through 17-Sep

      • EMG.LN (Man Group) -- facing internal resistance as it pushes employees to sign stricter non-compete agreements - FT

      • BALD.B.SS (Fastighets Balder) -- appoints Sharam Rahi as new CEO; shareholders also announce intentions to propose to the nomination committee that Erik Selin be elected Executive Chairman at the AGM in 2026

  • Key rating changes

    • Upgrades

      • AGR.LN (Assura) -- to buy from add at Peel Hunt

      • MTRO.LN (Metro Bank Holdings) -- to outperform from sector perform at RBC Capital Markets

      • RWE.GR (RWE) -- to buy from hold at Deutsche Bank (earlier, timing uncertain)

    • Downgrades

      • MRK.GR (Merck KGaA) -- to equal weight from overweight at Barclays

      • LGEN.LN (Legal & General Group) -- to neutral from buy at UBS

      • DWL.LN (Dowlais Group Plc) -- to sector perform from outperform at RBC Capital Markets

      • DOC.AV (DO & CO) -- to hold from buy at Wood & Company

    • Initiations

      • ITRK.LN (Intertek Group) -- buy at Panmure Liberum (18-Aug, timing uncertain)

      • CIRSA.SM (Cirsa Enterprises) -- buy at Rothschild & Co Redburn

    • Other Actions

      • SWEC.B.SS (Sweco) -- reinstated buy at DNB Carnegie

      • FRES.LN (Fresnillo) -- transferred hold at Peel Hunt; prior rating was add

  • Data

    • Nikkei (0.13%) to 43656.84

    • Hang Seng +0.05% to 25190.30

    • Shanghai Composite +0.11% to 3732.08

    • S&P futures (13.5) vs prior close of 6469.3

    • €-$ (0.0004) or (0.03%) to 1.1659

    • $-¥ (0.19) or (0.13%) to 147.69

    • €-¥ (0.28) or (0.16%) to 172.17

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE